All roads lead to death panels – ctd.
While I’ve spent a few days calling out people I disagree with for their over-the-top rhetoric on the FDA and Avastin, it’s equally important to
While I’ve spent a few days calling out people I disagree with for their over-the-top rhetoric on the FDA and Avastin, it’s equally important to
The following appeared at Kaiser Health News on 19 August 2010. My announcement of the KHN version provoked many comments, to which I responded. In
the health services research blog
Work posted here under copyright © of the authors • Details on the Site Policies page